278
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Maternal and fetal Leptin and interleukin 33 concentrations in pregnancy complicated by obesity and preeclampsia

, , , , , , & show all
Pages 3942-3948 | Received 29 Oct 2018, Accepted 06 Mar 2019, Published online: 27 Mar 2019

References

  • Ogden CL, Carroll MD, Fryar CD, et al. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 2015;219(219):1–8.
  • Roberts JM, Bodnar LM, Patrick TE, et al. The role of obesity in preeclampsia. Pregnancy Hypertens. 2011;1(1):6–16.
  • Alfaradhi MZ, Kusinski LC, Fernandez-Twinn DS, et al. Maternal obesity in pregnancy developmentally programs adipose tissue inflammation in young, lean male mice offspring. Endocrinology. 2016;157(11):4246–4256.
  • Zambrano E, Ibáñez C, Martínez-Samayoa PM, et al. Maternal obesity: lifelong metabolic outcomes for offspring from poor developmental trajectories during the perinatal period. Arch Med Res. 2016;47(1):1–12.
  • Catalano P, de Mouzon SH. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. Int J Obes. 2015;39(4):642–649.
  • Brosens I, Pijnenborg R, Vercruysse L, et al. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
  • Pendeloski KPT, Ono E, Torloni MR, et al. Maternal obesity and inflammatory mediators: a controversial association. Am J Reprod Immunol. 2017;77(5):e12674.
  • Misra VK, Trudeau S. The influence of overweight and obesity on longitudinal trends in maternal serum leptin levels during pregnancy. Obesity. 2011;19(2):416–421.
  • Naylor C, Petri WA Jr. Leptin regulation of immune responses. Trends Mol Med. 2016;22(2):88–98.
  • Zavalza-Gómez AB, Anaya-Prado R, Rincón-Sánchez AR, et al. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract. 2008;80(1):8–15.
  • Taylor BD, Ness RB, Olsen J, et al. Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women. Hypertension. 2015;65(3):594–599.
  • Salimi S, Farajian-Mashhadi F, Naghavi A, et al. Different profile of serum leptin between early onset and late onset preeclampsia. Dis Markers. 2014;2014:1–7.
  • Castellano Filho DS, do Amaral Correa JO, Dos Santos Ramos P, et al. Body weight gain and serum leptin levels of non-overweight and overweight/obese pregnant women. Med Sci Monit. 2013;19:1043–1049.
  • Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479–490.
  • Martin MU. Special aspects of interleukin-33 and the IL-33 receptor complex. Semin Immunol. 2013;25(6):449–457.
  • Xu D, Jiang HR, Li Y, et al. IL-33 exacerbates autoantibody-induced arthritis. J Immunol. 2010;184(5):2620–2626.
  • Liew FY. IL-33: a Janus cytokine. Ann Rheum Dis. 2012;71(Suppl 2):i101–i104.
  • Palmer G, Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol. 2011;7(6):321–329.
  • Ohno T, Morita H, Arae K, et al. Interleukin-33 in allergy. Allergy. 2012;67(10):1203–1214.
  • Hasan A, Al-Ghimlas F, Warsame S, et al. IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects. BMC Immunol. 2014;15:19.
  • Miller AM, Asquith DL, Hueber AJ, et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res. 2010;107(5):650–658.
  • Wood IS, Wang B, Trayhurn P. IL-33, a recently identified interleukin-1 gene familymember, is expressed in human adipocytes. Biochem Biophys Res Commun. 2009;384(1):105–109.
  • Granne I, Southcombe JH, Snider JV, et al. ST2 and IL-33 in pregnancy and pre-eclampsia. PLOS ONE. 2011;6(9):e24463.
  • Eda Gökdemir İ, Özdeğirmenci Ö, Elmas B, et al. Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia. J Matern Fetal Neonatal Med. 2016;29(15):2451–2456.
  • Stampalija T, Chaiworapongsa T, Romero R, et al. Soluble ST2, a modulator of the inflammatory response, in preterm and term labor. J Matern Fetal Neonatal Med. 2014;27(2):111–121.
  • Romero R, Chaemsaithong P, Tarca AL, et al. Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia – a longitudinal study. J Matern Fetal Neonatal Med. 2018;31(4):418–432.
  • Pintaudi B, Fresa R, Dalfrà M, et al. Level of implementation of guidelines on screening and diagnosis of gestational diabetes: a national survey. Diabetes Res Clin Pract. 2016;113:48–52.
  • ACOG Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99(1):159–167.
  • Khalil A, Nicolaides KH. How to record uterine artery Doppler in the first trimester. Ultrasound Obstet Gynecol. 2013;42(4):478–479.
  • Gómez O, Figueras F, Fernández S, et al. Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound Obstet Gynecol. 2008;32(2):128–132.
  • Arduini D, Rizzo G. Normal values of pulsatility Index from fetal vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med. 1990;18(3):165–172.
  • Ego A. Definitions: small for gestational age and intrauterine growth retardation. J Gynecol Obstet Biol Reprod (Paris). 2013;42(8):872–894.
  • Hendler I, Blackwell SC, Mehta SH, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol. 2005;193(3 Pt 2):979–983.
  • Sagawa N, Yura S, Itoh H, et al. Possible role of placental leptin in pregnancy: a review. Endocrine. 2002;19(1):65–71.
  • Biesiada LA, Głowacka E, Krekora M, et al. The impact of excessive maternal weight on the nutritional status of the fetus – the role of leptin. Arch Med Sci. 2016;12(2):394–401.
  • Ren X, Guo M, Liu C, et al. A case-control study indicates that no Association Exists between polymorphisms of IL-33 and IL-1RL1 and preeclampsia. Cell Physiol Biochem. 2016;38(4):1406–1414.
  • Gajardo Carrasco T, Morales RA, Pérez F, et al. Alarmin’ immunologists: il-33 as a putative target for modulating T cell-dependent responses. Front Immunol. 2015;6:232.
  • Stampalija T, Chaiworapongsa T, Romero R, et al. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med. 2013;26(14):1359–1370.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.